Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain
- PMID: 9797247
- PMCID: PMC105987
- DOI: 10.1128/AAC.42.11.3022
Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain
Abstract
The susceptibilities of 143 Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens isolates to 18 antimicrobial agents were tested. All P. gingivalis isolates were susceptible. In contrast, some Prevotella spp. (17%) were resistant to beta-lactams, erythromycin, clindamycin, or tetracycline and carried resistance genes, ermF or tetQ, or beta-lactamases.
References
-
- Bernal L A, Guillot E, Paquet C, Mouton C. β-Lactamase-producing strains in the species Prevotella intermedia and Prevotella nigrescens. Oral Microbiol Immunol. 1998;13:36–40. - PubMed
-
- Brook, I. 1988. Synergy between spiramycin and metronidazole in the treatment of polymicrobial infections. J. Antimicrob. Chemother. 22(Suppl. BP):77–85. - PubMed
-
- Conrads G, Pelz K, Hughes B, Seyfarth I, Devine D A. Optimized oligonucleotides for the differentiation of Prevotella intermedia and Prevotella nigrescens. Oral Microbiol Immun. 1997;12:117–120. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
